Birdshot chorioretinopathy

Kayur H. Shah, Ralph D. Levinson, Fei Yu, Raquel Goldhardt, Lynn K. Gordon, Christine R. Gonzales, John R. Heckenlively, Peter J. Kappel, Gary N. Holland

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Birdshot chorioretinopathy is a well-known, yet poorly understood, form of posterior uveitis, characterized by multiple, distinctive, hypopigmented choroidal lesions, and strongly associated with human leukocyte antigen (HLA)-A29. We reviewed all English language publications regarding birdshot chorioretinopathy and performed analyses of combined patient data taken from these articles. The mean age at presentation was 53 years, with a slight female predominance (54.1%). At least 95.7% of reported patients have been HLA-A29-positive. Blurring of vision and floaters are the most prevalent presenting complaints, even in patients with visual acuity of 20/20 or better in both eyes. Birdshot chorioretinopathy is a slowly progressive disease with profound dysfunction of vision that may not be reflected in Snellen visual acuity. Two or more lines of Snellen visual acuity were lost in approximately 20% of eyes over a median follow-up of 3.5 years; macular edema was the most common cause of reduced visual acuity. Overall, patients had a slow decline in visual acuity, despite the fact that nearly all were treated with anti-inflammatory therapies. Final visual acuity in the better eye was 20/40 or better in 75.1% of patients and 20/200 or worse in 9.8% of patients. Oral corticosteroids and cyclosporine were the most commonly used medications. Using a regression model, patients in the literature that have been treated with cyclosporine alone had better final visual acuity than patients treated with oral corticosteroids alone. Further study is needed to determine the optimal methods for treating and monitoring patients with birdshot chorioretinopathy.

Original languageEnglish
Pages (from-to)519-541
Number of pages23
JournalSurvey of Ophthalmology
Volume50
Issue number6
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Visual Acuity
N,N-dimethyl-3,3-diphenyl-1-methylallylamine
HLA Antigens
Cyclosporine
Adrenal Cortex Hormones
Posterior Uveitis
Macular Edema
Birdshot chorioretinopathy
Physiologic Monitoring
Publications
Anti-Inflammatory Agents
Language

Keywords

  • Birdshot chorioretinopathy
  • Choroidal lesions
  • HLA-A29
  • Optic disk edema
  • Posterior uveitis
  • Retinal vasculitis
  • Vitiliginous chorioretinitis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Shah, K. H., Levinson, R. D., Yu, F., Goldhardt, R., Gordon, L. K., Gonzales, C. R., ... Holland, G. N. (2005). Birdshot chorioretinopathy. Survey of Ophthalmology, 50(6), 519-541. https://doi.org/10.1016/j.survophthal.2005.08.004

Birdshot chorioretinopathy. / Shah, Kayur H.; Levinson, Ralph D.; Yu, Fei; Goldhardt, Raquel; Gordon, Lynn K.; Gonzales, Christine R.; Heckenlively, John R.; Kappel, Peter J.; Holland, Gary N.

In: Survey of Ophthalmology, Vol. 50, No. 6, 01.11.2005, p. 519-541.

Research output: Contribution to journalArticle

Shah, KH, Levinson, RD, Yu, F, Goldhardt, R, Gordon, LK, Gonzales, CR, Heckenlively, JR, Kappel, PJ & Holland, GN 2005, 'Birdshot chorioretinopathy', Survey of Ophthalmology, vol. 50, no. 6, pp. 519-541. https://doi.org/10.1016/j.survophthal.2005.08.004
Shah KH, Levinson RD, Yu F, Goldhardt R, Gordon LK, Gonzales CR et al. Birdshot chorioretinopathy. Survey of Ophthalmology. 2005 Nov 1;50(6):519-541. https://doi.org/10.1016/j.survophthal.2005.08.004
Shah, Kayur H. ; Levinson, Ralph D. ; Yu, Fei ; Goldhardt, Raquel ; Gordon, Lynn K. ; Gonzales, Christine R. ; Heckenlively, John R. ; Kappel, Peter J. ; Holland, Gary N. / Birdshot chorioretinopathy. In: Survey of Ophthalmology. 2005 ; Vol. 50, No. 6. pp. 519-541.
@article{5c774fb0bdae4459a8542c859ea5548f,
title = "Birdshot chorioretinopathy",
abstract = "Birdshot chorioretinopathy is a well-known, yet poorly understood, form of posterior uveitis, characterized by multiple, distinctive, hypopigmented choroidal lesions, and strongly associated with human leukocyte antigen (HLA)-A29. We reviewed all English language publications regarding birdshot chorioretinopathy and performed analyses of combined patient data taken from these articles. The mean age at presentation was 53 years, with a slight female predominance (54.1{\%}). At least 95.7{\%} of reported patients have been HLA-A29-positive. Blurring of vision and floaters are the most prevalent presenting complaints, even in patients with visual acuity of 20/20 or better in both eyes. Birdshot chorioretinopathy is a slowly progressive disease with profound dysfunction of vision that may not be reflected in Snellen visual acuity. Two or more lines of Snellen visual acuity were lost in approximately 20{\%} of eyes over a median follow-up of 3.5 years; macular edema was the most common cause of reduced visual acuity. Overall, patients had a slow decline in visual acuity, despite the fact that nearly all were treated with anti-inflammatory therapies. Final visual acuity in the better eye was 20/40 or better in 75.1{\%} of patients and 20/200 or worse in 9.8{\%} of patients. Oral corticosteroids and cyclosporine were the most commonly used medications. Using a regression model, patients in the literature that have been treated with cyclosporine alone had better final visual acuity than patients treated with oral corticosteroids alone. Further study is needed to determine the optimal methods for treating and monitoring patients with birdshot chorioretinopathy.",
keywords = "Birdshot chorioretinopathy, Choroidal lesions, HLA-A29, Optic disk edema, Posterior uveitis, Retinal vasculitis, Vitiliginous chorioretinitis",
author = "Shah, {Kayur H.} and Levinson, {Ralph D.} and Fei Yu and Raquel Goldhardt and Gordon, {Lynn K.} and Gonzales, {Christine R.} and Heckenlively, {John R.} and Kappel, {Peter J.} and Holland, {Gary N.}",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.survophthal.2005.08.004",
language = "English",
volume = "50",
pages = "519--541",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Birdshot chorioretinopathy

AU - Shah, Kayur H.

AU - Levinson, Ralph D.

AU - Yu, Fei

AU - Goldhardt, Raquel

AU - Gordon, Lynn K.

AU - Gonzales, Christine R.

AU - Heckenlively, John R.

AU - Kappel, Peter J.

AU - Holland, Gary N.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Birdshot chorioretinopathy is a well-known, yet poorly understood, form of posterior uveitis, characterized by multiple, distinctive, hypopigmented choroidal lesions, and strongly associated with human leukocyte antigen (HLA)-A29. We reviewed all English language publications regarding birdshot chorioretinopathy and performed analyses of combined patient data taken from these articles. The mean age at presentation was 53 years, with a slight female predominance (54.1%). At least 95.7% of reported patients have been HLA-A29-positive. Blurring of vision and floaters are the most prevalent presenting complaints, even in patients with visual acuity of 20/20 or better in both eyes. Birdshot chorioretinopathy is a slowly progressive disease with profound dysfunction of vision that may not be reflected in Snellen visual acuity. Two or more lines of Snellen visual acuity were lost in approximately 20% of eyes over a median follow-up of 3.5 years; macular edema was the most common cause of reduced visual acuity. Overall, patients had a slow decline in visual acuity, despite the fact that nearly all were treated with anti-inflammatory therapies. Final visual acuity in the better eye was 20/40 or better in 75.1% of patients and 20/200 or worse in 9.8% of patients. Oral corticosteroids and cyclosporine were the most commonly used medications. Using a regression model, patients in the literature that have been treated with cyclosporine alone had better final visual acuity than patients treated with oral corticosteroids alone. Further study is needed to determine the optimal methods for treating and monitoring patients with birdshot chorioretinopathy.

AB - Birdshot chorioretinopathy is a well-known, yet poorly understood, form of posterior uveitis, characterized by multiple, distinctive, hypopigmented choroidal lesions, and strongly associated with human leukocyte antigen (HLA)-A29. We reviewed all English language publications regarding birdshot chorioretinopathy and performed analyses of combined patient data taken from these articles. The mean age at presentation was 53 years, with a slight female predominance (54.1%). At least 95.7% of reported patients have been HLA-A29-positive. Blurring of vision and floaters are the most prevalent presenting complaints, even in patients with visual acuity of 20/20 or better in both eyes. Birdshot chorioretinopathy is a slowly progressive disease with profound dysfunction of vision that may not be reflected in Snellen visual acuity. Two or more lines of Snellen visual acuity were lost in approximately 20% of eyes over a median follow-up of 3.5 years; macular edema was the most common cause of reduced visual acuity. Overall, patients had a slow decline in visual acuity, despite the fact that nearly all were treated with anti-inflammatory therapies. Final visual acuity in the better eye was 20/40 or better in 75.1% of patients and 20/200 or worse in 9.8% of patients. Oral corticosteroids and cyclosporine were the most commonly used medications. Using a regression model, patients in the literature that have been treated with cyclosporine alone had better final visual acuity than patients treated with oral corticosteroids alone. Further study is needed to determine the optimal methods for treating and monitoring patients with birdshot chorioretinopathy.

KW - Birdshot chorioretinopathy

KW - Choroidal lesions

KW - HLA-A29

KW - Optic disk edema

KW - Posterior uveitis

KW - Retinal vasculitis

KW - Vitiliginous chorioretinitis

UR - http://www.scopus.com/inward/record.url?scp=27444434792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27444434792&partnerID=8YFLogxK

U2 - 10.1016/j.survophthal.2005.08.004

DO - 10.1016/j.survophthal.2005.08.004

M3 - Article

C2 - 16263368

AN - SCOPUS:27444434792

VL - 50

SP - 519

EP - 541

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 6

ER -